{"paper_id":"74a9a5d1-858a-411c-8454-5fd4e4a78c1e","body_text":"Abstract\nIntroduction\nControlled ovarian stimulation (COS) with intrauterine insemination (IUI) is an effective treatment in cases of cervical factor, unexplained infertility and mild male factor. The optimal timing of IUI after human chorionic gonadotrophin (hCG) after COS with clomiphene citrate is debatable and may be a factor limiting success of same. This study was designed to scientifically determine if variation in the timing of IUI could affect the cycle outcome.\nMaterials and methods\nIn a prospective randomized trial couples with mild male factor, unexplained infertility and mild endometriosis who underwent COS with IUI were recruited. COS was achieved with clomiphene citrate. Two hundred and four women underwent 461 cycles of IUI. Women were randomized to two groups: group I (104 patients, 231 cycles) had IUI 36 h after hCG, while group II (100 patients, 230 cycles) had IUI 24 h after hCG. Primary outcome included pregnancy rate per couple and per cycle.\nResults\nFifty-four patients had pregnancy with and pregnancy rate per couple and per cycle were 32.6 and 14.7% in group I and 20 and 8.6% in group II, respectively (not statistically different).\nConclusions\nAltering timing of IUI after COS does not enhance pregnancy rates. IUI 36 h after hCG has marginally better pregnancy rates than 24 h. Timing of insemination may be kept at 24 or 36 h after hCG injection to suit the convenience of the clinic or care provider. The lack of statistical significance indicates need for larger studies to draw guidelines.\nSimilar content being viewed by others\nReferences\nGoverde AJ, McDonnell J, Vermeiden JP, Schats R, Rutten FF, Schoemaker J (2000) Intrauterine insemination or in vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet 355(9197):13–18\nCohlen BJ, te Velde ER, van Kooij RJ (1995) Is there still a place for intra-uterine insemination as a treatment for male subfertility? A review. Int J Androl 18(Suppl 2):72–75 (review)\nRagni G, Somigliana E, Vegetti W (2004) Timing of intrauterine insemination: where are we? Fertil Steril 82(1):25–26 (discussion 32–35; review)\nCampana A, Sakkas D, Stalberg A, Bianchi PG et al (1996) Intrauterine insemination: evaluation of the results according to the woman’s age, sperm quality, total sperm count per insemination and life table analysis. Hum Reprod 11:732–736\nDuran HE, Morshedi M, Kruger T, Oehninger S (2002) Intrauterine insemination, a systematic review on determinants of success. Hum Reprod Update 8(4):373–384\nKhalil MR, Rasmussen PE, Erb K, Laursen SB, Rex S, Westergaard LG (2001) Homologous intrauterine insemination: an evaluation of prognostic factors based on a review of 2473 cycles. Acta Obstet Gynecol Scand 80:74–81\nDemir B, Dilbaz B, Cinar O, Karadag B, Tasci Y, Kocak M, Dilbaz S, Goktolga U (2011) Factors affecting pregnancy outcome of intrauterine insemination cycles in couples with favourable female characteristics. J Obstet Gynaecol 31(5):420–423\nOzçakir HT, Göker EN, Terek MC, Adakan S, Ulukus M, Levi R, Tavmergen E (2002) Relationship of follicle number, serum estradiol level, and other factors to clinical pregnancy rate in gonadotropin-induced intrauterine insemination cycles. Arch Gynecol Obstet 266(1):18–20\nDodson WC, Haney AF (1991) Controlled ovarian hyperstimulation and intrauterine insemination for treatment of infertility. Fertil Steril 55:457–467\nRobb PA, Robins JC, Thomas MA (2004) Timing of hCG administration does not affect pregnancy rates in couples undergoing intrauterine insemination using clomiphene citrate. J Natl Med Assoc 96(11):1431–1433\nWorld Health Organization (2001) Laboratory manual of the World Health Organization for the examination of human semen and sperm–cervical mucus interaction. Ann Ist Super Sanita (I–XII):1–123\nParikh FR, Nandkarni SG, Kamat SG, Naik N, Soonawala SB, Parikh RM (1997) Genital tuberculosis: a major pelvic factor causing infertility in Indian women. Fertil Steril 67:497–500\nRotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25\nZeyneloglu HB, Arici A, Duleba AJ (1998) Comparison of intrauterine insemination with timed intercourse in superovulated cycles with gonadotropins: a metanalysis. Fertil Steril 69:486–491\nKarande VC, Korn A, Morris R, Rao R, Balin M, Rinehart J (1999) Prospective randomized trial comparing the outcome and cost of in vitro fertilization with that of a traditional treatment algorithm as first-line therapy for couples with infertility. Fertil Steril 71(3):468–475\nTempleton AA, van Look P, Angell RE, Aitken RJ, Lumsden MA, Baird DT (1986) Oocyte recovery and fertilization rates in women at various times after the administration of hCG. J Reprod Fertil 76(2):771–778\nAwonuga A, Govindbhai J (1999) Is waiting for an endogenous luteinizing hormone surge and/or administration of human chorionic gonadotrophin of benefit in intrauterine insemination? Hum Reprod 14(7):1765–1770\nWang YC, Chang YC, Chen IC, Cnien HH, Wu GJ (2006) Comparison of timing of IUI in ovarian stimulated cycles. Arch Androl 52(5):371–374\nPryor JL, Kuneck P, Blatz SM et al (2001) Delayed timing of intrauterine insemination results in a significantly improved pregnancy rate in female partners of quadriplegic men. Fertil Steril 76:1130–1135\nSunde A, Kahn JA, Molne K (1988) Intrauterine insemination: a European collaborative report. Hum Reprod 2:69–73\nEdwards RG, Steptoe PC (1974) Control of human ovulation, fertilization and implantation. Proc R Soc Med 67:932–9359\nKucuk T (2008) Intrauterine insemination: is the timing correct? J Assist Reprod Genet 25(8):427–430 (Epub 2 Sep 2008)\nPeterson CM, Hatasaka HH, Jones KP et al (1994) Ovulation induction with gonadotropins and intrauterine insemination compared with in vitro fertilization and no therapy: a prospective, nonrandomized, cohort study and meta-analysis. Fertil Steril 62:535–544\nBrzechffa PR, Daneshmand S, Buyalos RP (1998) Sequential clomiphene citrate and human menopausal gonadotrophin with intrauterine insemination: the effect of patient age on clinical outcome. Hum Reprod 13:2110–2114\nTomilson MJ, Amissah-Arthur JB, Thompson KA, Kasraie JL, Bentick B (1996) Prognostic indicators for IUI: statistical model for IUI success. Hum Reprod 11(9):1892–1896\nRahman SM, Malhotra N, Kumar S, Roy KK, Agarwal A (2010) A randomized controlled trial comparing the effectiveness of single versus double intrauterine insemination in unexplained infertility. Fertil Steril 94(7):2913–2915 (Epub 1 Aug 2010)\nChavkin D, Molinaro T, Roe A, Sammel M, Dokras A (2011) Donor sperm insemination cycles: are two inseminations better than one? J Androl (Epub ahead of print)\nAcknowledgments\nWe thank the institute ethics committee for clearing this randomized control trial.\nConflict of interest\nNone.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nRights and permissions\nAbout this article\nCite this article\nRahman, S.M., Karmakar, D., Malhotra, N. et al. Timing of intrauterine insemination: an attempt to unravel the enigma. Arch Gynecol Obstet 284, 1023–1027 (2011). https://doi.org/10.1007/s00404-011-1950-6\nReceived:\nAccepted:\nPublished:\nIssue date:\nDOI: https://doi.org/10.1007/s00404-011-1950-6","source_license":"public-domain-us","license_restricted":false}